2-{4-[4-(2,4-Dichlorophenoxy)-5-methyl-1H-pyrazol-3-yl]-3-hydroxyphenoxy}acetamide

ID: ALA5208075

Chembl Id: CHEMBL5208075

PubChem CID: 168297899

Max Phase: Preclinical

Molecular Formula: C18H15Cl2N3O4

Molecular Weight: 408.24

Names and Identifiers

Canonical SMILES:  Cc1[nH]nc(-c2ccc(OCC(N)=O)cc2O)c1Oc1ccc(Cl)cc1Cl

Standard InChI:  InChI=1S/C18H15Cl2N3O4/c1-9-18(27-15-5-2-10(19)6-13(15)20)17(23-22-9)12-4-3-11(7-14(12)24)26-8-16(21)25/h2-7,24H,8H2,1H3,(H2,21,25)(H,22,23)

Standard InChI Key:  PKAHQWXNYWRKGW-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5208075

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 408.24

Molecular Weight (Monoisotopic): 407.0440

AlogP: 4.05

#Rotatable Bonds: 6

Polar Surface Area: 110.46

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.25

CX Basic pKa: 1.88

CX LogP: 3.43

CX LogD: 3.37

Aromatic Rings: 3

Heavy Atoms: 27

QED Weighted: 0.57

Np Likeness Score: -1.15

References

1. Khiar-Fernández N, Zian D, Vázquez-Villa H, Martínez RF, Escobar-Peña A, Foronda-Sainz R, Ray M, Puigdomenech-Poch M, Cincilla G, Sánchez-Martínez M, Kihara Y, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S..  (2022)  Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA₂), UCM-14216, Ameliorates Spinal Cord Injury in Mice.,  65  (16.0): [PMID:35948083] [10.1021/acs.jmedchem.2c00046]

Source

Source(1):

• Scientific Literature